Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Study Comparing Preoperative Chemoradiotherapy Alone Versus Neoadjuvant Chemotherapy With Folfirinox Regimen Followed by Preoperative Chemoradiotherapy for Patients With Resectable Locally Advanced Rectal Cancer

NCT01804790 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT01804790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01804790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Study Comparing Preoperative Chemoradiotherapy Alone Versus Neoadjuvant Chemotherapy With Folfirinox Regimen Followed by Preoperative Chemoradiotherapy for Patients With Resectable Locally Advanced Rectal Cancer
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2012
Completion date
July 1, 2023
Enrollment
461 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the rectum